Company · CIK 0000920148 · SIC 8071 — Services-Medical Laboratories · NYSE
LABCORP HOLDINGS INC. · LH
Insider activity reported against this company. All insider holders · Files at: SQNM. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 SForm 4 → | Aug 18, 8:10 am EDT | Kerrii B AndersonDirector | 3,000 | $318.02 | $954,060 | 6,563 | −31.4% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 12, 2:31 pm EDT | Adam H SchechterPresident & CEO, Director | 4,669 | $320.37 | $1,495,808 | 102,565 | −4.35% | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 8:26 am EDT | Amy B. SummyEVP, Chief Marketing Officer | 924 | $306.74 | $283,428 | 6,956 | −11.7% | |
| Aug 3, 2026 MForm 4 → | Aug 5, 11:17 am EDT | Peter J WilkinsonSVP, Chief Accounting Officer | 1,338 | $209.25 | $279,977 | 3,108 | — | |
| Aug 3, 2026 SForm 4 → | Aug 5, 11:17 am EDT | Peter J WilkinsonSVP, Chief Accounting Officer | 1,420 | $309.23 | $439,107 | 1,770 | −44.5% | |
| Jul 2, 2026 SForm 4 → | Jul 6, 9:37 am EDT | Kathryn W KyleEVP, Chief Legal Officer | 92 | $286.19 | $26,329 | 3,904 | −2.30% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 6, 9:36 am EDT | Bryan T VaughnEVP and President, Diagnostics | 234 | $286.19 | $66,968 | 6,746 | −3.35% | 10b5-1 |
| Jul 1, 2026 FMForm 4 → | Jul 6, 9:37 am EDT | Kathryn W KyleEVP, Chief Legal Officer | 329 | $283.88 | $20,723 | 3,996 | — | 10b5-1 |
| Jul 1, 2026 FMForm 4 → | Jul 6, 9:36 am EDT | Bryan T VaughnEVP and President, Diagnostics | 420 | $283.88 | $26,401 | 6,980 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 3, 8:21 am EDT | Akinbolade OyegunwaEVP, CIO & CTO | 750 | — | — | 2,940 | — | |
| Sep 1, 2026 AForm 4 → | Sep 3, 8:19 am EDT | Jonathan C MeltzerEVP, COO | 900 | — | — | 3,594 | — | |
| Sep 1, 2026 AForm 4 → | Sep 3, 8:18 am EDT | Bryan T VaughnEVP and President, Diagnostics | 1,500 | — | — | 5,204 | — | |
| Sep 1, 2026 AForm 4 → | Sep 3, 8:07 am EDT | Brian J CaveneyEVP, Pres of BLS, CMO & CSO | 3,000 | — | — | 7,170 | — | |
| Aug 3, 2026 MForm 4 → | Aug 5, 11:17 am EDT | Peter J WilkinsonSVP, Chief Accounting Officer | 1,338 | — | — | 0 | — | |
| Jul 1, 2026 MForm 4 → | Jul 6, 9:37 am EDT | Kathryn W KyleEVP, Chief Legal Officer | 256 | — | — | 2,008 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 9:36 am EDT | Bryan T VaughnEVP and President, Diagnostics | 327 | — | — | 3,704 | — | 10b5-1 |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.